MALAT1 and carcinoma: A short 16-mer ASO gapmer with phosphorothioate-modified S-2′-O-ethylene-2′,4′-bridged nucleic acid targeted MALAT1 in an MMTV-PyMT carcinoma model, rendering slower tumor growth and reduced metastasis [11].